本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Soleno Therapeutics

79.38
+1.782.29%
盘后79.380.00000.00%17:34 EDT
成交量:77.76万
成交额:6,133.10万
市值:40.00亿
市盈率:-17.09
高:79.62
开:77.96
低:76.92
收:77.60
数据加载中...
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/19

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/21

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/10

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/19

重要事件披露

Form 8-K - Current report
2024/07/19

重要事件披露

Form 8-K - Current report